Commercialization Education
|
|
New! Idea to Impact Commercialization Webinar Series
|
|
Idea to Impact is a new seven-part, á la carte webinar series intended to educate and connect life science researchers and academic innovators from across the state in the commercialization of academic research.
The FFMI team has worked with leading biomedical researchers from the University of Michigan and surrounding institutions to put together this series that will help participants learn how to translate a research-based idea into a product of impact, and outline the significance and critical milestones necessary to develop:
- novel therapeutics
- medical devices
- diagnostics
- digital health innovations
- essential collaborations with industry partners
The webinars will take place every two weeks, beginning June 17, 2020.
CLICK HERE for a complete list of webinars, dates, and times.
Even if you’ve participated in an FFMI education course or program in the past, the webinars will serve both as valuable refresher for what you’ve learned, as well as cover a variety of new information and helpful material.
Questions? Email Jon Servoss, FFMI Director of Commercialization Education, at
servossj@umich.edu.
|
|
FFMI
fast
PACE Fall Cohort Registration Available
|
|
FFMI
fast
PACE is a 4-week biomedical and commercialization course designed to help participants prepare a successful business case for funding and development partnerships.
Registration is now available for the Fall cohort beginning September 25. Sign up today!
|
|
|
Cheers to the Latest Kickstart Awardees
|
|
The new Kickstart teams are:
David Fox, M.D.
U-M Rheumatology
Evidence for targeting NK cell CD6 as a breast cancer immunotherapy
Howard Petty, Ph.D.
U-M Ophthalmology
Prediction of cancer recurrences using biomarkers
Marlene Seltzer, M.D.
Beaumont - Obstetrics & Gynecology
John Farris, Ph.D.
Grand Valley State - Engineering
Labor Assist Device
|
FFMI is now accepting proposals for the next round of Kickstart applications, due Saturday, August 1. Questions? Contact Sara Risch, Biomedical Innovation Specialist, at johnssar@umich.edu or 734-764-5598.
|
|
Michigan Medicine: Positioned to Lead in Technology-Driven Research
|
|
COVID-19 has disrupted everyone's lives, especially those working within health care. But this disruption has also accelerated technology-driven research - with much of that work being performed at Michigan Medicine.
Digital data gathering, artificial intelligence, precision health, real-time feedback monitoring, and virtual clinical trial validation will become positive by-products of what many industry experts call "health care's Amazon moment."
Seizing on that moment, Michigan Medicine researchers turned to technology to fight the virus.
|
|
Get the Latest News on Projects and Teams that Received FFMI Funding, Training, and Support
|
|
Genomenon, a
Michigan Biomedical Venture Fund portfolio company and
MTRAC award winner, closed an oversubscribed funding round in May, which will enable them to continue on their strong growth trajectory. The company continues to announce new partnerships, such as with the precision medicine and digital health company,
EnGenome.
Learn more about how Genomenon is helping others make big strides in rare disease diagnosis and drug development in
this interview with Mike Klein, CEO of Genomenon, in
Rare Revolution Magazine.
|
|
COVID19 Well-Being Help Center
|
|
During the COVID-19 pandemic, it is important for Michigan Medicine faculty, staff, and learners, as well as members of the larger community, to take care of themselves.
|
|
Internal Funding to Support COVID-19 Metabolic Research
|
|
MDiabetes has announced a call for proposals for up to $50,000 to study the impact of COVID-19 on, and to improve the care of, those with diabetes and related disorders.
Applications will be accepted on a rolling basis, with funding available immediately.
DEADLINE: Rolling
|
|
|
2020 Massey Family Foundation Traumatic Brain Injury Virtual Grand Challenge
|
|
The Massey TBI Grand Challenge is made possible thanks to a generous gift from the Joyce and Don Massey Family Foundation. Up to $650,000 is available in 2020 to fund the development of diagnostic, device, therapeutic, or health IT solutions that address the initial "golden hours" of care after severe traumatic brain injury (generally the first 48 hours). Additionally, this year ALL current/past awardees and new awardees will be eligible for the Schwabauer Accelerator Award of $40,000. This will be a separate application.
|
|
|
How Has COVID-19 Affected Your Research?
|
|
The University of Michigan has partnered with teams at Harvard and Northwestern Universities to survey the changing nature of academic work amid the COVID-19 crisis. Your response will help us understand how your work has been impacted, and what might be necessary for a successful future.
|
|
|
MICHR Enables U-M's Physicians to Request Remdesivir Through Expanded Access
|
|
At Michigan Medicine, U-M' s physicians can now request remdesivir for critically ill patients before the clinical trial is open at Michigan Medicine, for patients who were too young to qualify for the trial, and for other qualifying circumstances through Emergency Use Authorization. Remdesivir, an investigational antiviral drug, is theorized to have efficacy against SARS-CoV2, the type of coronavirus that causes COVID-19.
|
|
|
Deerfield Commits Up to $130M to Commercialize Drug Discovery at U-M
|
|
A new partnership between the University of Michigan and health care investment firm Deerfield Management Co. will create a company to commercialize therapeutic projects that hold promise in solving unmet medical needs.
On May 27, U-M and Deerfield announced the launch of Great Lakes Discoveries LLC. Deerfield has committed up to $130 million over the next decade to invest in biomedical research at U-M with the aim of developing potentially life-saving drugs and disease treatments.
|
|
|
UMOR to Offer Virtual Grantsmanship Series
|
|
This summer, UMOR's Research Development team will present Grantsmanship 101, a series of webinars aimed at enhancing grantseeking know-how for researchers pursuing external funding. The webinars will include a range of skill-building topics, such as understanding funding organizations, how to align proposals with funder priorities, how to write for reviewers, and how to craft specific aims pages and other proposal documents. Anyone in the U-M research community may register through the links below; webinars will be recorded and made available through the
U-M Research Development website.
|
|
Michigan Medicine Offers Balance with Data-Sharing
|
|
A new framework published in the
New England Journal of Medicine could help medical centers that share data do so more responsibly, going beyond the minimum legal requirements and respecting patients by giving them more say in how their individual data may be used. Written by a team from Michigan Medicine, the authors lay out an approach already applied to thousands of U-M patients and research study volunteers, and dozens of projects.
|
|
|
Underground Research Opportunity Program Now Recruiting Research Projects for 2020-2021
|
|
Would you like help getting a new research project started or expediting a current project? Do you want to gain experience mentoring undergraduates?
The
Undergraduate Research Opportunity Program (UROP) is now accepting research project submissions for the next academic year. Due to COVID-19 circumstances, we encourage you to think about the elements of your project that can be done remotely and those that require in-person work. This will be helpful as decisions are being made about students returning fully or partially to campus in the fall.
If you would like more information or are ready to mentor a UROP student, visit our
website or contact Luciana Nemtanu, UROP Associate Director, at
lucianab@umich.edu.
|
|
|
To better navigate the complexities of the U-M biomedical research enterprise, visit the
Research Project Lifecycle
. This interactive tool provides an overview of the resources available to you, not only within the Medical School Office of Research but also across the University of Michigan.
|
|
Fast Forward Medical Innovation
is part of the Office of Research, where our mission is to foster an environment of innovation and efficiency that serves the U-M Medical School community and supports biomedical science from insight to impact.
|
|
|
|
|
|
|
